Novo Nordisk wins EU approval for Wegovy pill and new injection
Go back to Novo Nordisk wins EU approval for Wegovy pill and new injection| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.24 +0.05 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.19 | 52 Week High | $59.00 | |||
| Open | $43.50 | 52 Week Low | $32.80 | |||
| Day High | $43.54 | P/E | N/A | |||
| Day Low | $42.78 | EPS | $0.00 | |||
| Volume | 10,367,788 | |||||
